Tech Company Financing Transactions
CytoPherx Funding Round
CytoPherx closed a $34 million funding round on 1/4/2012. Investors included Aphelion Capital, APIDC Venture Capital Limited and Capital Midwest Fund.
Transaction Overview
Company Name
Announced On
1/4/2012
Transaction Type
Venture Equity
Amount
$34,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The funds will be used to complete U. S. clinical trials and gain FDA approval to commercialize the CytoPherx anti-inflammatory therapy for acute kidney injury.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
401 West Morgan Road
Ann Arbor, MI 48108
USA
Ann Arbor, MI 48108
USA
Phone
Website
Email Address
Not Recorded
Overview
Out of business.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Danehy
Browse more venture capital transactions:
Prev: 1/3/2012: Next Big Sound venture capital transaction
Next: 1/4/2012: Wantworthy venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs